论文部分内容阅读
[目的]:肝脏是结直肠癌血行转移的最常见部位,约50%的结直肠癌病人发生肝转移,并有25%的病人早期就出现肝转移,而前瞻性随机抽样的临床分析表明,结直肠癌肝转移病人的结直肠局部切除及其他辅助治疗,不足以延长病人的生命,故目前许多专家认为肝切除术是结直肠癌肝转移的标准治疗措施。本文研究的重点是结直肠癌肝转移病人肝切除术后肝功能变化的特点及生存期的估计。 [方法]:对25例结直肠Ca发生肝转移而行肝切除术的病人进行研究。25例病人中,13例为同时病灶,12例为异时病灶。12例行楔形切除术,7例行右侧肝小叶切除,另6例行右三单叶切除术。术前临床表现、肝脏生化及术中肝脏触诊,可发现一些潜在
[Objective] Liver is the most common site of hematogenous metastasis in colorectal cancer, with approximately 50% of patients with colorectal cancer undergoing hepatic metastases and 25% of patients with early hepatic metastases, and prospective randomized clinical analyses have shown that Local colorectal resection and other adjuvant treatments for patients with colorectal liver metastases are not enough to prolong the lives of patients. Therefore, many experts believe that hepatectomy is the standard treatment for colorectal liver metastases. The focus of this study is the characteristics of liver function changes after liver resection in patients with colorectal liver metastases and the estimation of survival. [Methods]: 25 cases of liver metastases from colorectal Ca undergoing hepatectomy were studied. Of the 25 patients, 13 were simultaneous lesions and 12 were allotopic lesions. 12 patients underwent wedge resection, 7 patients underwent right hepatic lobectomy, and 6 patients underwent right unilobectomy. Preoperative clinical manifestations, liver biochemistry, and intraoperative palpation of the liver can reveal some potential